Increase in alveolar antioxidant levels in hyperoxic and anoxic ventilated rabbit lungs during ischemia

Free Radical Biology and Medicine

Volumn 36, Issue 1, 2004, Pages 78-89

  Schmidt, Reinhold ^a   Schäfer, Christoph ^a   Luboeinski, Thomas ^a   Löckinger, Alexander ^a   Hermle, Gerd ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a   Ghofrani, Ardeschir ^a   Schütte, Hartwig ^a   Günther, Andreas ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acute lung injury; Alveolar antioxidants; Free radicals; Ischemia reperfusion syndrome; Lung transplantation

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; ISOPROSTANE; LUNG SURFACTANT; PLASMALOGEN; RETINOL; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL HOST; FEMALE; FUNCTIONAL ASSESSMENT; HYPEROXIA; LUNG ALVEOLUS CARBON DIOXIDE TENSION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS SURFACE TENSION; LUNG INJURY; LUNG LAVAGE; LUNG PERFUSION; MALE; NONHUMAN; OXIDATIVE STRESS; OXYGEN ENHANCEMENT RATIO; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SPECIES COMPARISON;

ORYCTOLAGUS CUNICULUS;

EID: 0347318127     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.10.023     Document Type: Article

References (77)

1. Hefner E.J., Repine E.J. Pulmonary strategies of antioxidant defense. Am. Rev. Respir. Dis. 140:1989;531-554.
2. Fisher A.B., Dodia C., Tan Z., Ayene I., Eckenhoff R.G. Oxygen-dependent lipid peroxidation during lung ischemia. J. Clin. Invest. 88:1991;674-679.
3. Matot I., Manevich Y., Al-Mehdi A.B., Song C., Fisher A.B. Fluorescence imaging of lipid peroxidation in isolated rat lungs during nonhypoxic lung ischemia. Free Radic. Biol. Med. 15:2003;785-790.
4. Putman E., Van Golde L.M., Haagsman H.P. Toxic oxidant species and their impact on the pulmonary surfactant system. Lung. 175:1997;75-103.
5. Williams A., Riise G.C., Anderson B.A., Kjellstrom C., Schersten H., Kelly F.J. Compromised antioxidant status and persistent oxidative stress in lung transplant recipients. Free Radic. Res. 30:1999;383-393.
6. Kennedy P.T., Rao V.N., Hopkins C., Pennington L., Tolley E., Hoidal R.J. Role of reactive oxygen species in reperfusion injury of the rabbit lung. J. Clin. Invest. 83:1989;1326-1335.
7. Inci I., Inci D., Dutly A., Boehler A., Weder W. Melatonin attenuates posttransplant lung ischemia-reperfusion injury. Ann. Thorac. Surg. 73:2002;220-225.
8. Kozower B.D., Christofidou-Solomidou M., Sweitzer T.D., Muro S., Buerk D.G., Solomides C.C., Albelda S.M., Patterson G.A., Muzykantov V.R. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat. Biotechnol. 21:2003;392-398.
9. 2- isoprostane generation in isolated ferret lungs after oxidant injury or ventilated ischemia. Free Radic. Biol. Med. 25:1998;703-711.
10. Akashi A., Nakahara K., Kamiike W., Matsumura A., Hatanaka N., Kawashima Y., Yoshida Y., Tagawa K. Attenuation of warm ischemic injury of rat lung by inflation with room air: assessment of cellular components and the surfactant in the bronchoalveolar lavage fluid in relation to changes in cellular adenosine triphosphate. Transplantation. 55:1993;24-30.
11. Minamiya Y., Tozawa K., Kitamura M., Saito S., Ogawa J. Platelet-activating factor mediates intercellular adhesion molecule-1-dependent radical production in the nonhypoxic ischemia rat lung. Am. J. Respir. Cell Mol. Biol. 19:1998;150-157.
12. Sanders S.P., Bassett D.J., Harrison S.J., Pearse D., Zweier J.L., Becker P.M. Measurements of free radicals in isolated, ischemic lungs and lung mitochondria. Lung. 178:2000;105-118.
13. Schutte H., Lockinger A., Seeger W., Grimminger F. Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion. Eur. Respir. J. 18:2001;15-22.
14. Hohlfeld J.M., Struber M., Ahlf K., Hoeper M.M., Fraund S., Krug N., Warnecke G., Harringer W., Haverich A., Fabel H. Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur. Respir. J. 13:1999;1037-1043.
15. Featherstone R.L., Chambers D.J., Kelly F.J. Ischemic preconditioning enhances recovery of isolated rat lungs after hypothermic preservation. Ann. Thorac. Surg. 69:2000;237-242.
16. Friedrich I., Spillner J., Lu E.X., Bartling B., Barnscheid M., Sablotzki A., Schade U., Reidemeister J.C., Silber R.E., Gunther A., Borgermann J. Ischemic preconditioning of 5 minutes but not of 10 minutes improves lung function after warm ischemia in a canine model. J. Heart Lung Transplant. 20:2001;959-985.
17. Schutte H., Hermle G., Seeger W., Grimminger F. Vascular distension and continued ventilation are protective in lung ischemia/reperfusion. Am. J. Respir. Crit. Care Med. 157:1998;171-177.
18. Okuda M., Furuhashi K., Nakai Y., Muneyuki M. Decrease of ischemia-reperfusion related lung oedema by continuous ventilation and allopurinol in rat perfusion model. Scand. J. Clin. Lab. Invest. 53:1993;625-631.
19. Hamvas A., Park C.K., Palazzo R., Liptay M., Cooper J., Schuster D.P. Modifying pulmonary ischemia-reperfusion injury by altering ventilatory strategies during ischemia. J. Appl. Physiol. 73:1992;2112-2119.
20. 2-dependent hydroxyl radical production during ischemia-reperfusion lung injury. Am. J. Physiol. 265:1993;L279-L285.
21. Zhao G., al-Mehdi A.B., Fisher A.B. Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am. J. Physiol. 273:1997;L1112-L1117.
22. Haddad J.J. Oxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiology. Respir. Res. 3:2002;1-27.
23. Ochs M., Nenadic I., Fehrenbach A., Albes J.M., Wahlers T., Richter J., Fehrenbach H. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am. J. Respir. Crit. Care Med. 160:1999;718-724.
24. Veldhuizen R.A., Lee J., Sandler D., Hull W., Whitsett J.A., Lewis J.F., Possmayer F., Novick R.J. Alteration in pulmonary surfactant composition and activity after experimental lung transplantation. Am. Rev. Respir. Dis. 148:1993;208-215.
25. Gunther A., Balser M., Schmidt R., Markart P., Olk A., Borgermann J., Splittgerber F., Seeger W., Friedrich I. Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration. J. Thorac. Cardiovasc. Surg. 2004;. In press.
26. Gilliard N., Heldt G.P., Loredo J., Redl H., Merritt T.A., Spragg R.G. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties. J. Clin. Invest. 93:1994;2608-2615.
27. Seeger W., Lepper H., Wolf D.H., Neuhof H. Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro. Biochim. Biophys. Acta. 835:1985;58-67.
28. Guthmann F., Kolleck I., Schachtrup C., Schlame M., Spencer F., Rustow B. Vitamin E deficiency reduces surfactant lipid biosynthesis in alveolar type II cells. Free Radic. Biol. Med. 34:2003;663-673.
29. Kelly F.J., Buhl R., Sandstrom T. Measurement of antioxidants, oxidants and oxidation products in bronchoalveolar lavage fluid. Eur. Respir. Rev. 9:1999;93-98.
30. Kelly F.J., Mudway I., Blomberg A., Frew A., Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet. 354:1999;482-483.
31. Slade R., Crissman K., Norwood J., Hatch G. Comparison of antioxidant substances in bronchoalveolar lavage cells and fluid from humans, guinea pigs, and rats. Exp. Lung Res. 19:1993;469-484.
32. Van der Vliet A., O'Neill C.A., Cross C.E., Koostra J.M., Volz W.G., Halliwell B., Louie S. Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. Am. J. Physiol. 276:1999;L289-L296.
33. Roch-Ramel F., Peters G. Urinary excretion of uric acid in non-human mammalian species. Kelley W.N., Weimer I.M. Handbook of experimental pharmacology. Uric acid. Vol. 51:1978;Springer-Verlag, Berlin.
34. Seeger W., Walmrath D., Grimminger F., Rosseau S., Schutte H., Kramer H.J., Ermert L., Kiss L. Adult respiratory distress syndrome: model systems using isolated perfused rabbit lungs. Methods Enzymol. 233:1994;549-584.
35. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
36. Rouser G., Fleischer S., Yamamoto A. Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids. 5:1970;494-496.
37. Gunther A., Siebert C., Schmidt R., Ziegler S., Grimminger F., Yabut M., Temmesfeld B., Walmrath D., Morr H., Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am. J. Respir. Crit. Care Med. 153:1996;176-184.
38. Schmidt R., Meier U., Yabut-Perez M., Walmrath D., Grimminger F., Seeger W., Gunther A. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome (ARDS) and severe pneumonia. Am. J. Respir. Crit. Care Med. 163:2001;95-100.
39. Eder K. Gas chromatographic analysis of fatty acid methyl esters. J. Chromatogr. B. 671:1995;113-131.
40. Kramer H.J., Schmidt R., Gunther A., Becker G., Suzuki Y., Seeger W. ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 152:1995;1540-1544.
41. Schmidt R., Steinhilber W., Ruppert C., Daum C., Grimminger F., Seeger W., Gunther A. An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 165:2002;470-474.
42. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
43. Baker M.A., Cerniglia G.J., Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal. Biochem. 190:1990;360-365.
44. Jaeschke H., Mitchell J.R. Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress. Methods Enzymol. 186:1990;752-759.
45. Catignani G.L., Bieri J.G. Simultaneous determination of retinol and α-tocopherol in serum or plasma by liquid chromatography. Clin. Chem. 29:1983;708-712.
46. Iriyama K., Yoshiura M., Iwamoto T., Ozaki Y. Simultaneous determination of uric and ascorbic acid in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection. Anal. Biochem. 141:1984;238-243.
47. Bunnell E., Pacht E.R. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148:1993;1174-1178.
48. Proudfoot J., Barden A., Mori T.A., Burke V., Croft K.D., Beilin L.J., Puddey I.B. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation: a comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal. Biochem. 272:1999;209-215.
49. Carpenter C.T., Price P.V., Christman B.W. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest. 114:1998;1653-1659.
50. Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., Barnes P.J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am. J. Respir. Crit. Care Med. 160:1999;216-220.
51. Jenkinson S.G., Black R.D., Lawrence R.A. Glutathione concentrations in rat lung bronchoalveolar lavage fluid: effects of hyperoxia. J. Lab. Clin. Med. 112:1988;345-351.
52. Cantin A.M., North S.L., Hubbard R.C., Crystal R.G. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63:1987;152-157.
53. Smith L.J., Houston M., Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am. Rev. Respir. Dis. 147:1993;1461-1464.
54. Pacht E.R., Timerman A.P., Lykens M.G., Merola A.J. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest. 100:1991;1397-1403.
55. Rahman I., Skwarska E., Henry M., Davis M., O'Connor C.M., FitzGerald M.X., Greening A., MacNee W. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic. Biol. Med. 27:1999;60-68.
56. Kelly F.J., Blomberg A., Frew A., Holgate S.T., Sandstrom T. Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide. Am. J. Respir. Crit. Care Med. 154:1996;1700-1705.
57. Kelly F.J., Tetley T.D. Nitrogen dioxide depletes uric acid and ascorbic acid but not glutathione from lung lining fluid. Biochem. J. 325:1997;95-99.
58. 31P-NMR spectroscopy. Biochemistry. 32:1993;27-31.
59. Rustow B., Kolleck I., Guthmann F., Haupt R., Kunze D., Stevens P. Synthesis and secretion of plasmalogens by type-II pneumocytes. Biochem. J. 302:1994;665-668.
60. Zoeller R.A., Morand O.H., Raetz C.R. A possible role for plasmalogens in protecting animal cells against photosensitized killing. J. Biol. Chem. 263:1988;11590-11596.
61. Sindelar P.J., Guan Z., Dallner G., Emster L. The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic. Biol. Med. 26:1999;318-324.
62. Rudiger M., von Baehr A., Haupt R., Wauer R.R., Rustow B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit. Care Med. 28:2000;1572-1577.
63. Freeman B.A., Crapo J.D. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 256:1981;10986-10992.
64. Haramaki N., Stewart D.B., Aggarwal S., Ikeda H., Reznick A.Z., Packer L. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion. Free Radic. Biol. Med. 25:1998;329-339.
65. Sato P.H., Hall E.D. Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury. J. Neurochem. 58:1992;2263-2268.
66. Kodavanti U.P., Costa D.L., Dreher K.L., Crissman K., Hatch G.E. Ozone-induced tissue injury and changes in antioxidant homeostasis in normal and ascorbate-deficient guinea pigs. Biochem. Pharmacol. 17:1995;243-251.
67. Jackson R.M., Frank L. Ozone-induced tolerance to hyperoxia in rats. Am. Rev. Respir. Dis. 129:1984;425-429.
68. Clerch L.B., Massaro D. Tolerance of rats to hyperoxia: lung antioxidant enzyme gene expression. J. Clin. Invest. 91:1993;499-508.
69. Vento G., Mele M.C., Mordente A., Romagnoli C., Matassa P.G., Zecca E., Zappacosta B., Persichilli S. High total antioxidant activity and uric acid in tracheobronchial aspirate fluid of preterm infants during oxidative stress: an adaptive response to hyperoxia? Acta Paediatr. 89:2000;336-342.
70. 2 tolerance in rabbits with no increase in antioxidant enzymes. J. Appl. Physiol. 66:1989;1679-1684.
71. Haddad J.J. Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. Cell. Signal. 14:2002;799-810.
72. Rahman I., Bel A., Mulier B., Donaldson K., MacNee W. Differential regulation of glutathione by oxidants and dexamethasone in alveolar epithelial cells. Am. J. Physiol. 275:1998;L80-L86.
73. Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 16:2000;534-554.
74. Rahman I., Bel A., Mulier B., Lawson M.F., Harrison D.J., MacNee W., Smith C.A. Transcriptional regulation of gamma-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. Biochem. Biophys. Res. Commun. 24:1996;832-837.
75. Crim C., Simon R.H. Effects of oxygen metabolites on rat alveolar type II cell viability and surfactant metabolism. Lab. Invest. 58:1988;428-437.
76. Haagsmann H.P., Schuurmans E.A., Batenburg J.J., Van Golde L.M. Synthesis of phosphatidylcholine in ozone-exposed alveolar type II cells isolated from adult rat lung: is glycerolphosphate acyltransferase a rate-limiting enzyme? Exp. Lung Res. 14:1988;1-17.
77. Schmidt R., Meier U., Markart P., Grimminger F., Velcovsky H.G., Morr H., Seeger W., Gunther A. Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. Am. J. Physiol. 283:2002;L1079- L1085.